Personal information

No personal information available

Activities

Collapse all

Works (2)

Response to: ‘Correspondence on ‘Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial“ by Bredemeier

Annals of the Rheumatic Diseases
2022-12 | Journal article
DOI: 10.1136/annrheumdis-2020-218960
Contributors: James R Seibold; Veronika Kohlbrenner; Margarida Alves; Oliver Distler
Source: check_circle
Crossref

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

Annals of the Rheumatic Diseases
2020-11 | Journal article
DOI: 10.1136/annrheumdis-2020-217331
Contributors: James R Seibold; Toby M Maher; Kristin B Highland; Shervin Assassi; Arata Azuma; Laura Kathleen Hummers; Ulrich Costabel; Ute von Wangenheim; Veronika Kohlbrenner; Martina Gahlemann et al.
Source: check_circle
Crossref

Peer review (16 reviews for 5 publications/grants)

Review activity for Arthritis & rheumatology. (4)
Review activity for Arthritis care & research. (2)
Review activity for Journal of scleroderma and related disorders. (6)
Review activity for Rheumatology (2)
Review activity for The journal of rheumatology. (2)
How many people are using ORCID?